Public Comment on Draft Recommendation StatementAgency for Healthcare Research and Quality (AHRQ) sent this bulletin at 04/16/2013 08:00 AM EDT
Medications for Risk Reduction of Primary Breast Cancer in Women
The U.S. Preventive Services Task Force posted today for public comment its draft Recommendation Statement on medications for risk reduction of primary breast cancer in women. The draft Recommendation Statement is available for review and public comment from April 16 through May 13, 2013. To review the draft Recommendation Statement and submit comments, go to http://www.uspreventiveservicestaskforce.org/tfcomment.htm.